{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T02:58:26Z","timestamp":1760151506485,"version":"build-2065373602"},"reference-count":23,"publisher":"Georg Thieme Verlag KG","issue":"06","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol Surg A Cent Eur Neurosurg"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Adamantinomatous craniopharyngioma (ACP) is the most common type of craniopharyngioma (CP). Under the current surgery and\/or radiotherapy strategies, the survival rate is high, but the long-term quality of life is poor because of the relationship between the hypothalamic\u2013pituitary axis and the tumor. Many studies had shown that endocrine deficiencies caused by craniopharyngiomas of the hypothalamic\u2013pituitary axis persist throughout almost the entire life of the patients after surgery, requiring them to receive hormone replacement therapy. Thus, we need to explore new treatments to improve the prognosis of patients. In recent years, there are more and more studies on the immunotherapy of various tumors. However, due to the rarity of the disease, immunotherapy for ACP is rarely researched. The discovery of the tumor immune-suppressive checkpoint KLRB1 (killer cell lectinlike receptor B1), which encodes CD161, may provide a novel target for the treatment of ACP.<\/jats:p><jats:p>Data analysis of retrospective RNA sequencing was conducted in a cohort of 51 pediatric samples in the GSE94349 dataset, and the results were well validated in the GSE68015 dataset including 31 pediatric samples. We used R language as the main tool for statistical analysis and graphical work.<\/jats:p><jats:p>Our research showed that KLRB1 was enriched in ACP. Additionally, the expression of KLRB1 was positively related to immune functions and most inflammatory responses of ACP. We found that most of the T lineage\u2013related immune responses were positively correlated with KLRB1 expression, and KLRB1 played an important role in the activation of inflammatory processes.<\/jats:p><jats:p>\n                  KLRB1 is a promising target for immunotherapeutic strategies.<\/jats:p>","DOI":"10.1055\/a-2312-9813","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T19:02:36Z","timestamp":1713985356000},"page":"524-531","source":"Crossref","is-referenced-by-count":2,"title":["Analysis of KLRB1-Mediated Immunosuppressive Regulation in Adamantinomatous Craniopharyngioma"],"prefix":"10.1055","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-0507-417X","authenticated-orcid":false,"given":"Wei","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Hong","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2024,7,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/B978-0-444-59602-4.00016-2","article-title":"Craniopharyngioma","volume":"124","author":"H L M\u00fcller","year":"2014","journal-title":"Handb Clin Neurol"},{"issue":"03","key":"ref2","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s11060-011-0540-6","article-title":"Incidence of craniopharyngioma in Denmark (n = 189) and estimated world incidence of craniopharyngioma in children and adults","volume":"104","author":"E H Nielsen","year":"2011","journal-title":"J Neurooncol"},{"issue":"08","key":"ref3","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/neuonc\/nos142","article-title":"Incidence, treatment and survival of patients with craniopharyngioma in the surveillance, epidemiology and end results program","volume":"14","author":"B E Zacharia","year":"2012","journal-title":"Neuro-oncol"},{"issue":"01","key":"ref4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41572-019-0125-9","article-title":"Craniopharyngioma","volume":"5","author":"H L M\u00fcller","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"01","key":"ref5","first-page":"25","article-title":"Surgical aspects in craniopharyngioma treatment","volume":"6","author":"S Fujio","year":"2020","journal-title":"Innov Surg Sci"},{"issue":"11","key":"ref6","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3390\/cancers10110401","article-title":"Dosimetric comparison of proton radiation therapy, volumetric modulated arc therapy, and three-dimensional conformal radiotherapy based on intracranial tumor location","volume":"10","author":"S Adeberg","year":"2018","journal-title":"Cancers (Basel)"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1016\/j.wneu.2021.06.119","article-title":"Health-related quality of life in adult patients with craniopharyngioma","volume":"154","author":"K Lucia","year":"2021","journal-title":"World Neurosurg"},{"issue":"03","key":"ref8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1055\/s-0034-1368785","article-title":"Childhood craniopharyngioma: changes of treatment strategies in the trials KRANIOPHARYNGEOM 2000\/2007","volume":"226","author":"A Hoffmann","year":"2014","journal-title":"Klin Padiatr"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"882381","DOI":"10.3389\/fendo.2022.882381","article-title":"Neoadjuvant B-RAF and MEK inhibitor targeted therapy for adult papillary craniopharyngiomas: a new treatment paradigm","volume":"13","author":"F Calvanese","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"05","key":"ref10","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.cell.2021.01.022","article-title":"Inhibitory CD161 receptor identified in glioma-infiltrating T cells by single-cell analysis","volume":"184","author":"N D Mathewson","year":"2021","journal-title":"Cell"},{"issue":"21","key":"ref11","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.7150\/jca.63236","article-title":"CD161, a promising immune checkpoint, correlates with patient prognosis: a pan-cancer analysis","volume":"12","author":"W Ye","year":"2021","journal-title":"J Cancer"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"688215","DOI":"10.3389\/fimmu.2021.688215","article-title":"A pan-cancer analysis of CD161, a potential new immune checkpoint","volume":"12","author":"X Zhou","year":"2021","journal-title":"Front Immunol"},{"issue":"09","key":"ref13","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/jnen\/nlx061","article-title":"Molecular analyses reveal inflammatory mediators in the solid component and cyst fluid of human adamantinomatous craniopharyngioma","volume":"76","author":"A M Donson","year":"2017","journal-title":"J Neuropathol Exp Neurol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40478-015-0211-5","article-title":"Identification of targets for rational pharmacological therapy in childhood craniopharyngioma","volume":"3","author":"J M Gump","year":"2015","journal-title":"Acta Neuropathol Commun"},{"issue":"02","key":"ref15","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1186\/bcr2234","article-title":"T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers","volume":"11","author":"A Rody","year":"2009","journal-title":"Breast Cancer Res"},{"issue":"11","key":"ref16","doi-asserted-by":"crossref","first-page":"e1196310","DOI":"10.1080\/2162402X.2016.1196310","article-title":"Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain glioma","volume":"5","author":"Z Wang","year":"2016","journal-title":"OncoImmunology"},{"issue":"01","key":"ref17","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11102-012-0401-0","article-title":"Childhood craniopharyngioma","volume":"16","author":"H L M\u00fcller","year":"2013","journal-title":"Pituitary"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1007\/s00381-021-05277-7","article-title":"An analysis of clinical characteristics and postoperative complications in children craniopharyngioma","volume":"37","author":"D Yaxian","year":"2021","journal-title":"Childs Nerv Syst"},{"issue":"12","key":"ref19","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s00381-010-1245-4","article-title":"The role of inflammation in the genesis of the cystic component of craniopharyngiomas","volume":"26","author":"B L Pettorini","year":"2010","journal-title":"Childs Nerv Syst"},{"issue":"02","key":"ref20","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3390\/jcm9020519","article-title":"The inflammatory milieu of adamantinomatous craniopharyngioma and its implications for treatment","volume":"9","author":"R Whelan","year":"2020","journal-title":"J Clin Med"},{"issue":"9255","key":"ref21","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to Virchow?","volume":"357","author":"F Balkwill","year":"2001","journal-title":"Lancet"},{"issue":"06","key":"ref22","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.3892\/mmr.2017.6538","article-title":"Interleukin\u20136 induces an epithelial\u2013mesenchymal transition phenotype in human adamantinomatous craniopharyngioma cells and promotes tumor cell migration","volume":"15","author":"J Zhou","year":"2017","journal-title":"Mol Med Rep"},{"issue":"02","key":"ref23","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/stem.2267","article-title":"Concise review: paracrine role of stem cells in pituitary tumors: a focus on adamantinomatous craniopharyngioma","volume":"34","author":"J P Martinez-Barbera","year":"2016","journal-title":"Stem Cells"}],"container-title":["Journal of Neurological Surgery Part A: Central European Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2312-9813.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T22:42:26Z","timestamp":1760136146000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2312-9813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,24]]},"references-count":23,"journal-issue":{"issue":"06","published-online":{"date-parts":[[2025,10,10]]},"published-print":{"date-parts":[[2025,11]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2312-9813","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2193-6315","2193-6323"],"issn-type":[{"type":"print","value":"2193-6315"},{"type":"electronic","value":"2193-6323"}],"subject":[],"published-other":{"date-parts":[[2024,4,24]]},"published":{"date-parts":[[2024,4,24]]}}}